Fig. 2From: Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective studyKaplanāMeier plot of survival at 90Ā daysThe solid line represents patients in the severe coagulopathy group, and the dotted line represents patients in the mild coagulopathy group. The mortality rate was significantly different between the two groups.Back to article page